5th International Conference on Pediatrics and Child Health

Pediatric Neurology & Neurodevelopmental Medicine brings together pediatric neurologists, developmental pediatricians, neurogeneticists, psychologists, neuroscientists, therapists, nurses, researchers, and healthcare professionals to discuss advances in neurological and neurodevelopmental disorders in children. The session focuses on epilepsy, autism, ADHD, neurogenetic disorders, neuromuscular conditions, neurocritical care, advanced neuroimaging, and emerging technologies for early diagnosis and personalized treatment.

Key Discussion Areas

• Pediatric Epilepsy and Seizure Management – advanced diagnosis, seizure monitoring, drug-resistant epilepsy, and emerging treatments.
• Autism, ADHD and Neurodevelopment – early diagnosis, developmental assessment, behavioral interventions, and multidisciplinary care.
• Neurogenetics and Emerging Therapies – genetic testing, precision medicine, neuromuscular disorders, biomarkers, and targeted therapies.
• Neuroimaging, Neurocritical Care and Digital Innovation – advanced imaging, acute neurological emergencies, AI-assisted diagnosis, and digital tools.

Benefits of Attending This Session

Pediatric neurologists, developmental specialists, neurogeneticists, psychologists, therapists, nurses, researchers, and healthcare professionals can gain insights into emerging diagnostic and therapeutic approaches. The session provides opportunities to present neurological research, discuss complex clinical challenges, explore precision medicine and digital innovations, and develop multidisciplinary collaborations.

Frequently Asked Questions

Q: Are studies on autism, ADHD, epilepsy, and neurodevelopmental disorders suitable for presentation?

A: Yes. The session welcomes clinical research, translational studies, neuroimaging research, genetic studies, therapeutic interventions, case studies, and multidisciplinary approaches related to pediatric neurology and neurodevelopment.

Q: Will the session address emerging genetic and technology-based approaches?

A: Yes. Topics may include genomic testing, precision medicine, AI-assisted neuroimaging, digital health tools, biomarkers, and emerging therapies for neurological and neurodevelopmental disorders.